Uses of Coxid 450mg Capsule
Coxid 450mg Capsule is used for the treatment or prevention of the following disease(s):
Tuberculosis (TB)
Side effects of Coxid 450mg Capsule
Precautions while taking Coxid 450mg Capsule
Dosage of Coxid 450mg Capsule
Overdose of Coxid 450mg Capsule
Onset of Action of Coxid 450mg Capsule
Duration of Action of Coxid 450mg Capsule
Precautions & Warnings
Alcohol
Information will be added soon.
Pregnancy
Information will be added soon.
Breastfeeding
Information will be added soon.
Driving
Information will be added soon.
Kidney
Information will be added soon.
Liver
Information will be added soon.
All substitutes for Coxid 450mg Capsule
For information purpose only. Refer to a healthcare professionals before consuming any medicines and/or drugs.
Interactions
Drug :-
aminophylline, oxtriphylline, theophylline: Increased metabolism and clearance of these theophylline preparations.
anesthetics hydrocarbon inhalation, except isoflurane, hepatotoxic drugs, isoniazid: Increased risk of hepatotoxicity.
beta blockers, chloramphenicol, clofibrate, corticosteroids, cyclosporine, dapsone, digitalis glycosides, disopyramide, hexobarbital, itraconazole, ketoconazole, mexiletine, oral anticoagulants, oral antidiabetic drugs, phenytoin, propafenone, quinidine, tocainide, verapamil oral: Increased metabolism, resulting in lower blood levels of these drug.
bone marrow depressants: Increased leukopenic or thrombocytopenic effects.
clofazimine: Reduced absorption of rifampin, delaying its peak concentration and increasing its half-life.
diazepam: Enhanced diazepam elimination, resulting in decreased drug effectiveness.
estramustine, estrogens, oral contraceptives: Decreased estrogenic effects.
methadone: Possibly impaired absorption of methadone, leading to withdrawal symptoms.
probenecid: Increased blood level or prolonged duration of rifampin, increasing risk of toxicity.
nonnucleoside reverse transcriptase inhibitors, protease inhibitors indinavir, nelfinavir, ritonavir, saquinavir: Accelerated metabolism of these drugs by patients with HIV, resulting in subtherapeutic levels,delayed metabolism of rifampin, increasing risk of toxicity.
trimethoprim: Increased elimination and shortened elimination half-life of trimethoprim.
vitamin D: Increased metabolism and decreased efficacy of vitamin D, leading to decreased serum calcium and phosphate levels and increased parathyroid hormone levels.
Activity :-
alcohol use: Increased risk of hepatotoxicity.